Email this article 
Photobiomodulation and Alzheimer's Disease:Review
Abstract
Alzheimer's disease (AD) is one of the basic neurodegenerative diseases and the most extreme common state of dementia. Described through the loss of learning, memory, critical thinking, language, and different abilities to address, AD applies an adverse consequence on every patients' and families' style of life. Despite the fact that there were enormous advances in data , the basic pathogenesis and progression of AD, there's no solution for AD. The disappointment of several molecular focused pharmacologic clinical preliminaries closes in a rising research shift towards non-invasive medicines. We, first and foremost, assessed the pathological changes of AD and the requesting circumstances for AD research. We then, at that point, added those non-invasive medicines and referenced the components which can affect the results of those therapies. Furthermore, we assessed the results of those therapies and the suitable components underlying those outcomes. At long last, we summed up the requesting circumstances of the Photobiomodulation cure in future AD studies and clinical applications. We presumed that it would be essential to perceive the exact fundamental components and find the optimal cure parameters to upgrade the translational value of the Photobiomodulation treatment.
Keywords
Full Text:
PDFReferences
- Liu, Pei-Pei, et al. "History and progress of hypotheses and clinical trials for Alzheimer’s disease." Signal transduction and targeted therapy 4.1 (2019): 29.
- DeTure, Michael A., and Dennis W. Dickson. "The
neuropathological diagnosis of Alzheimer’s disease." Molecular neurodegeneration 14.1 (2019): 32.
- Alzheimer's Association. "2019 Alzheimer's disease facts and figures." Alzheimer's & dementia 15.3 (2019): 321-387.
- Haque, Rafi U., and Allan I. Levey. "Alzheimer’s disease: A clinical perspective and future nonhuman primate research opportunities." Proceedings of the national Academy of Sciences 116.52 (2019): 26224-26229.
- Pandey, Gaurav, and Vibin Ramakrishnan. "Invasive and non-invasive therapies for Alzheimer’s disease and other amyloidosis." Biophysical Reviews 12 (2020): 1175-1186.
- Dompe, Claudia, et al. "Photobiomodulation—underlying mechanism and clinical applications." Journal of clinical medicine 9.6 (2020): 1724.
- Yang, Luodan, et al. "Photobiomodulation therapy attenuates anxious-depressive-like behavior in the TgF344 rat model." Journal of Alzheimer's Disease 83.4 (2021): 1415-1429.
- Yang, Luodan, et al. "Effects of prenatal photobiomodulation treatment on neonatal hypoxic ischemia in rat offspring." Theranostics 11.3 (2021): 1269.
- Wu, Chongyun, et al. "Effects of exercise training on anxious–depressive-like behavior in Alzheimer rat." Medicine and science in sports and exercise 52.7 (2020): 1456.
- Wu, Chongyun, et al. "Effects of exercise training on anxious–depressive-like behavior in Alzheimer rat." Medicine and science in sports and exercise 52.7 (2020): 1456.
- Chang, Chun-Hung, Hsien-Yuan Lane, and Chieh-Hsin Lin. "Brain stimulation in Alzheimer's disease." Frontiers in psychiatry 9 (2018): 329705.
- Kametani, Fuyuki, and Masato Hasegawa. "Reconsideration of amyloid hypothesis and tau hypothesis in Alzheimer's disease." Frontiers in neuroscience 12 (2018): 328460.
- Zheng, Hui, and Edward H. Koo. "Biology and pathophysiology of the amyloid precursor protein." Molecular neurodegeneration 6 (2011): 1-16.
- Hardy, John, and David Allsop. "Amyloid deposition as the central event in the aetiology of Alzheimer's disease." Trends in pharmacological sciences 12 (1991): 383-388.
- Nunan, Janelle, and David H. Small. "Regulation of APP cleavage by α-, β-and γ-secretases." FEBS letters 483.1 (2000): 6-10.
- Chow, Vivian W., et al. "An overview of APP processing enzymes and products." Neuromolecular medicine 12 (2010): 1-12.
- Miao, Jin, et al. "Pathological tau from Alzheimer’s brain induces site-specific hyperphosphorylation and SDS-and reducing agent-resistant aggregation of tau in vivo." Frontiers in aging neuroscience 11 (2019): 34.
- Gong, C-X., and Khalid Iqbal. "Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease." Current medicinal chemistry 15.23 (2008): 2321-2328.
- Barbier, Pascale, et al. "Role of tau as a microtubule-associated protein: structural and functional aspects." Frontiers in aging neuroscience 11 (2019): 204.
- Alonso, Alejandra D., et al. "Hyperphosphorylation of tau associates with changes in its function beyond microtubule stability." Frontiers in cellular neuroscience 12 (2018): 338.
- Yuan, Aidong, et al. "Neurofilament subunits are integral components of synapses and modulate neurotransmission and behavior in vivo." Molecular psychiatry 20.8 (2015): 986-994.
- Yang, Luodan, et al. "Mitochondria as a target for neuroprotection: role of methylene blue and photobiomodulation." Translational neurodegeneration 9 (2020): 1-22.
- Wang, Wenzhang, et al. "Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: Recent advances." Molecular neurodegeneration 15 (2020): 1-22.
- Tucker, Lorelei Donovan, et al. "Photobiomodulation therapy attenuates hypoxic-ischemic injury in a neonatal rat model." Journal of Molecular Neuroscience 65 (2018): 514-526.
- Youle, Richard J., and Alexander M. Van Der Bliek. "Mitochondrial fission, fusion, and stress." Science 337.6098 (2012): 1062-1065.
- Fu, Wenyan, Yang Liu, and Hang Yin. "Mitochondrial dynamics: biogenesis, fission, fusion, and mitophagy in the regulation of stem cell behaviors." Stem cells international 2019 (2019).
- Sun, Xiaonan, Jalen Alford, and Hongyu Qiu. "Structural and functional remodeling of mitochondria in cardiac diseases." International Journal of Molecular Sciences 22.8 (2021): 4167.
- Ren, Lin, et al. "Mitochondrial dynamics: fission and fusion in fate determination of mesenchymal stem cells." Frontiers in cell and developmental biology 8 (2020): 580070.
- Chen, Hsiuchen, and David C. Chan. "Emerging functions of mammalian mitochondrial fusion and fission." Human molecular genetics 14.suppl_2 (2005): R283-R289.
- Wang, Wenzhang, et al. "Inhibition of mitochondrial fragmentation protects against Alzheimer’s disease in rodent model." Human molecular genetics 26.21 (2017): 4118-4131.
- Manczak, Maria, Marcus J. Calkins, and P. Hemachandra Reddy. "Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage." Human molecular genetics 20.13 (2011): 2495-2509.
- Yao, Jia, et al. "Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease." Proceedings of the National Academy of Sciences 106.34 (2009): 14670-14675.
- Gibson, G. E., K-FR Sheu, and J. P. Blass. "Abnormalities of mitochondrial enzymes in Alzheimer disease." Journal of neural transmission 105 (1998): 855-870.
- Moreira, Paula I., et al. "Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology." Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1802.1 (2010): 2-10.
- Swerdlow, Russell H. "Mitochondria and mitochondrial cascades in Alzheimer’s disease." Journal of Alzheimer's Disease 62.3 (2018): 1403-1416.
- Armand-Ugon, Mercedes, et al. "Reduced mitochondrial activity is early and steady in the entorhinal cortex but it is mainly unmodified in the frontal cortex in Alzheimer's disease." Current Alzheimer Research 14.12 (2017): 1327-1334.
- Huang, Wen Juan, X. I. A. Zhang, and Wei Wei Chen. "Role of oxidative stress in Alzheimer's disease." Biomedical reports 4.5 (2016): 519-522.
- Zhao, Ru Zhou, et al. "Mitochondrial electron transport chain, ROS generation and uncoupling." International journal of molecular medicine 44.1 (2019): 3-15.
- Brand, Martin D. "Mitochondrial generation of superoxide and hydrogen peroxide as the source of mitochondrial redox signaling." Free Radical Biology and Medicine 100 (2016): 14-31.
- D'Autréaux, Benoît, and Michel B. Toledano. "ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis." Nature reviews Molecular cell biology 8.10 (2007): 813-824.
- Teixeira, Jéssika P., et al. "Future therapeutic perspectives into the Alzheimer’s disease targeting the oxidative stress hypothesis." Molecules 24.23 (2019): 4410.
- Srinivasan, Satish, and Narayan G. Avadhani. "Cytochrome c oxidase dysfunction in oxidative stress." Free Radical Biology and Medicine 53.6 (2012): 1252-1263.
- Pao, Ping-Chieh, et al. "HDAC1 modulates OGG1-initiated oxidative DNA damage repair in the aging brain and Alzheimer’s disease." Nature communications 11.1 (2020): 2484.
- Wu, Chongyun, et al. "Beneficial effects of exercise pretreatment in a sporadic Alzheimer’s rat model." Medicine and science in sports and exercise 50.5 (2018): 945.
- Chen, Zhichun, and Chunjiu Zhong. "Oxidative stress in Alzheimer’s disease." Neuroscience bulletin 30 (2014): 271-281.
- Hensley, Kenneth. "Neuroinflammation in Alzheimer's disease: mechanisms, pathologic consequences, and potential for therapeutic manipulation." Journal of Alzheimer's disease 21.1 (2010): 1-14.
- Lai, Aaron Y., and JoAnne McLaurin. "Clearance of amyloid-β peptides by microglia and macrophages: the issue of what, when and where." Future neurology 7.2 (2012): 165-176.
- Fakhoury, Marc. "Microglia and astrocytes in Alzheimer's disease: implications for therapy." Current neuropharmacology 16.5 (2018): 508-518.
- Ismail, Rola, et al. "The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer’s disease: a longitudinal PET study." Journal of neuroinflammation 17 (2020): 1-11.
- Tang, Yu, and Weidong Le. "Differential roles of M1 and M2 microglia in neurodegenerative diseases." Molecular neurobiology 53 (2016): 1181-1194.
- Shen, Zhiwei, Xinjie Bao, and Renzhi Wang. "Clinical PET imaging of microglial activation: implications for microglial therapeutics in Alzheimer’s disease." Frontiers in aging neuroscience 10 (2018): 314.
- Mandrekar-Colucci, Shweta, and Gary E. Landreth. "Microglia and inflammation in Alzheimer's disease." CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders) 9.2 (2010): 156-167.
- Malm, Tarja M., Taylor R. Jay, and Gary E. Landreth. "The evolving biology of microglia in Alzheimer's disease." Neurotherapeutics 12.1 (2015): 81-93.
- Mandrekar-Colucci, Shweta, J. Colleen Karlo, and Gary E. Landreth. "Mechanisms underlying the rapid peroxisome proliferator-activated receptor-γ-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's disease." Journal of Neuroscience 32.30 (2012): 10117-10128.
- Hsiao, Cheng-Chih, et al. "GPCRomics of homeostatic and disease-associated human microglia." Frontiers in immunology 12 (2021): 674189.
- Keren-Shaul, Hadas, et al. "A unique microglia type associated with restricting development of Alzheimer’s disease." Cell 169.7 (2017): 1276-1290.
- Frost, Georgia R., and Yue-Ming Li. "The role of astrocytes in amyloid production and Alzheimer's disease." Open biology 7.12 (2017): 170228.
- Kashon, Michael L., et al. "Associations of cortical astrogliosis with cognitive performance and dementia status." Journal of Alzheimer's Disease 6.6 (2004): 595-604.
- Mrak, Robert E., Jin G. Sheng, and W. Sue T. Griffin. "Correlation of astrocytic S100β expression with dystrophic neurites in amyloid plaques of Alzheimer's disease." Journal of neuropathology and experimental neurology 55.3 (1996): 273-279.
- Beach, Thomas G., and E. G. McGeer. "Lamina-specific arrangement of astrocytic gliosis and senile plaques in Alzheimer's disease visual cortex." Brain research 463.2 (1988): 357-361.
- González-Reyes, Rodrigo E., et al. "Involvement of astrocytes in Alzheimer’s disease from a neuroinflammatory and oxidative stress perspective." Frontiers in molecular neuroscience 10 (2017): 427.
- Liddelow, Shane A., et al. "Neurotoxic reactive astrocytes are induced by activated microglia." Nature 541.7638 (2017): 481-487.
- Grimaldi, Alfonso, et al. "Neuroinflammatory processes, A1 astrocyte activation and protein aggregation in the retina of Alzheimer’s disease patients, possible biomarkers for early diagnosis." Frontiers in neuroscience 13 (2019): 925.
- Joshi, Amit U., et al. "Fragmented mitochondria released from microglia trigger A1 astrocytic response and propagate inflammatory neurodegeneration." Nature neuroscience 22.10 (2019): 1635-1648.
- Neal, Matthew, et al. "Prokineticin‐2 promotes chemotaxis and alternative A2 reactivity of astrocytes." Glia 66.10 (2018): 2137-2157.
- Reichenbach, Nicole, et al. "Inhibition of Stat3‐mediated astrogliosis ameliorates pathology in an Alzheimer's disease model." EMBO molecular medicine 11.2 (2019): e9665.
- Ceyzériat, Kelly, et al. "Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer’s disease." Acta neuropathologica communications 6 (2018): 1-23.
- Daria, Anna, et al. "Young microglia restore amyloid plaque clearance of aged microglia." The EMBO journal 36.5 (2017): 583-603.
- Tao, Lechan, et al. "Microglia modulation with 1070-nm light attenuates Aβ burden and cognitive impairment in Alzheimer’s disease mouse model." Light: Science & Applications 10.1 (2021): 179.
- Iaccarino, Hannah F., et al. "Gamma frequency entrainment attenuates amyloid load and modifies microglia." Nature 540.7632 (2016): 230-235.
- McAlpine, Cameron S., et al. "Astrocytic interleukin-3 programs microglia and limits Alzheimer’s disease." Nature 595.7869 (2021): 701-706.
- Hamblin, Michael R. "Photobiomodulation for Alzheimer’s disease: Has the light dawned?." Photonics. Vol. 6. No. 3. MDPI, 2019.
- Hamblin, Michael R. "Photobiomodulation for the management of alopecia: mechanisms of action, patient selection and perspectives." Clinical, cosmetic and investigational dermatology (2019): 669-678.
- Mester, E. N. D. R. E., et al. "Stimulation of wound healing by laser rays." Acta chirurgica academiae scientiarum hungaricae 13.3 (1972): 315-324.
- Hamblin, Michael R. "Photobiomodulation or low-level laser therapy." Journal of biophotonics 9.11-12 (2016): 1122.
- Hopkins, J. Ty, et al. "Low-level laser therapy facilitates superficial wound healing in humans: a triple-blind, sham-controlled study." Journal of athletic training 39.3 (2004): 223.
- Mester, Endre, Andrew F. Mester, and Adam Mester. "The biomedical effects of laser application." Lasers in surgery and medicine 5.1 (1985): 31-39.
- Mester, E., et al. "Effect of laser rays on wound healing." The American Journal of Surgery 122.4 (1971): 532-535.
- Camacho, Angela Domínguez, Mateo Bravo Reyes, and Sergio Andrés Velasquez Cujar. "A systematic review of the effective laser wavelength range in delivering photobiomodulation for pain relief in active orthodontic treatment." International Orthodontics 18.4 (2020): 684-695.
- Langella, Luciana Gonçalves, et al. "Photobiomodulation therapy (PBMT) on acute pain and inflammation in patients who underwent total hip arthroplasty—a randomized, triple-blind, placebo-controlled clinical trial." Lasers in medical science 33 (2018): 1933-1940.
-Janzadeh, Atousa, et al. "Photobiomodulation therapy reduces apoptotic factors and increases glutathione levels in a neuropathic pain model." Lasers in medical science 31 (2016): 1863-1869.
-Leal-Junior, Ernesto Cesar Pinto. "Photobiomodulation therapy in skeletal muscle: from exercise performance to muscular dystrophies." Photomedicine and Laser Surgery 33.2 (2015): 53.
-Li, Yong, et al. "Photobiomodulation prevents PTSD-like memory impairments in rats." Molecular Psychiatry 26.11 (2021): 6666-6679.
-Hamblin, Michael R. "Shining light on the head: photobiomodulation for brain disorders." BBA clinical 6 (2016): 113-124.
-Wang, Yuguang, et al. "Red (660 nm) or near-infrared (810 nm) photobiomodulation stimulates, while blue (415 nm), green (540 nm) light inhibits proliferation in human adipose-derived stem cells." Scientific reports 7.1 (2017): 7781.
- Wang, Yuguang, et al. "Photobiomodulation (blue and green light) encourages osteoblastic-differentiation of human adipose-derived stem cells: role of intracellular calcium and light-gated ion channels." Scientific reports 6.1 (2016): 33719.
- Ezzati, Kamran, et al. "A comparative study of the dose-dependent effects of low level and high intensity photobiomodulation (laser) therapy on pain and electrophysiological parameters in patients with carpal tunnel syndrome: a randomized controlled trial." European journal of physical and rehabilitation medicine 56.6 (2020): 733-740.
- Zein, Randa, Wayne Selting, and Michael R. Hamblin. "Review of light parameters and photobiomodulation efficacy: dive into complexity." Journal of biomedical optics 23.12 (2018): 120901-120901.
- Chen, Yongmei, et al. "Thermal effects of transcranial near-infrared laser irradiation on rabbit cortex." Neuroscience letters 553 (2013): 99-103.
- Tunér, Jan, and Peter A. Jenkins. "Parameter reproducibility in photobiomodulation." Photomedicine and laser surgery 34.3 (2016): 91-92.
- de Carvalho, Alberito Rodrigo, et al. "Using a single dose of photobiomodulation (laser+ LED) to improve performance of lower limbs in functional test: Randomized clinical trial." Journal of Bodywork and Movement Therapies 28 (2021): 255-263.
- Liu, Xiao-Guang, et al. "Effects of low-level laser irradiation on rat skeletal muscle injury after eccentric exercise." Photomedicine and Laser Surgery 27.6 (2009): 863-869.
]93]- Keshri, Gaurav K., et al. "Photobiomodulation with pulsed and continuous wave near-infrared laser (810 nm, Al-Ga-As) augments dermal wound healing in immunosuppressed rats." PloS one 11.11 (2016): e0166705.
- Lu, Yujiao, et al. "Low-level laser therapy for beta amyloid toxicity in rat hippocampus." Neurobiology of aging 49 (2017): 165-182.
- Kim, Hong Bae, et al. "Pulse frequency dependency of photobiomodulation on the bioenergetic functions of human dental pulp stem cells." Scientific reports 7.1 (2017): 15927.
- Maksimovich, Ivan V. "Laser Technologies as a New Direction in Transcatheter Interventions." Photobiomodulation, Photomedicine, and Laser Surgery 37.8 (2019): 455-456.
- Chao, Linda L. "Effects of home photobiomodulation treatments on cognitive and behavioral function, cerebral perfusion, and resting-state functional connectivity in patients with dementia: a pilot trial." Photobiomodulation, photomedicine, and laser surgery 37.3 (2019): 133-141.
- Berman, Marvin H., et al. "Photobiomodulation with near infrared light helmet in a pilot, placebo controlled clinical trial in dementia patients testing memory and cognition." Journal of neurology and neuroscience 8.1 (2017).
- Saltmarche, Anita E., et al. "Significant improvement in cognition in mild to moderately severe dementia cases treated with transcranial plus intranasal photobiomodulation: case series report." Photomedicine and laser surgery 35.8 (2017): 432-441.
- Peck, Katlyn J., et al. "Music and memory in Alzheimer’s disease and the potential underlying mechanisms." Journal of Alzheimer's disease 51.4 (2016): 949-959.
- Jahn, Holger. "Memory loss in Alzheimer's disease." Dialogues in clinical neuroscience 15.4 (2013): 445-454.
- Kelley, Brendan J., and Ronald C. Petersen. "Alzheimer's disease and mild cognitive impairment." Neurologic clinics 25.3 (2007): 577-609.
- Salehpour, Farzad, et al. "Photobiomodulation therapy and the glymphatic system: promising applications for augmenting the brain lymphatic drainage system." International Journal of Molecular Sciences 23.6 (2022): 2975.
- Adaikkan, Chinnakkaruppan, et al. "Gamma entrainment binds higher-order brain regions and offers neuroprotection." Neuron 102.5 (2019): 929-943.
- Meng, Chengbo, Zhiyong He, and Da Xing. "Low-level laser therapy rescues dendrite atrophy via upregulating BDNF expression: implications for Alzheimer's disease." Journal of Neuroscience 33.33 (2013): 13505-13517.
- Meng, Chengbo, Zhiyong He, and Da Xing. "Low-level laser therapy rescues dendrite atrophy via upregulating BDNF expression: implications for Alzheimer's disease." Journal of Neuroscience 33.33 (2013): 13505-13517.
- Li, Yong, et al. "Transcranial photobiomodulation prevents PTSD-like comorbidities in rats experiencing underwater trauma." Translational Psychiatry 11.1 (2021): 270.
- Askalsky, Paula, and Dan V. Iosifescu. "Transcranial photobiomodulation for the management of depression: current perspectives." Neuropsychiatric disease and treatment (2019): 3255-3272.
- Caldieraro, Marco Antonio, et al. "Long-term near-infrared photobiomodulation for anxious depression complicated by Takotsubo cardiomyopathy." Journal of clinical psychopharmacology 38.3 (2018): 268-270.
- Salehpour, Farzad, Michael R. Hamblin, and Joseph O. DiDuro. "Rapid reversal of cognitive decline, olfactory dysfunction, and quality of life using multi-modality photobiomodulation therapy: case report." Photobiomodulation, photomedicine, and laser surgery 37.3 (2019): 159-167.
- Yang, Luodan, et al. "Photobiomodulation preconditioning prevents cognitive impairment in a neonatal rat model of hypoxia‐ischemia." Journal of biophotonics 12.6 (2019): e201800359.
-Hamblin, Michael R. "Mechanisms and mitochondrial redox signaling in photobiomodulation." Photochemistry and photobiology 94.2 (2018): 199-212.
- Yang, Luodan, et al. "Photobiomodulation therapy promotes neurogenesis by improving post-stroke local microenvironment and stimulating neuroprogenitor cells." Experimental neurology 299 (2018): 86-96.
- Poyton, Robert O., and Kerri A. Ball. "Therapeutic photobiomodulation: nitric oxide and a novel function of mitochondrial cytochrome c oxidase." Discovery medicine 11.57 (2011): 154-159.
- De Freitas, Lucas Freitas, and Michael R. Hamblin. "Proposed mechanisms of photobiomodulation or low-level light therapy." IEEE Journal of selected topics in quantum electronics 22.3 (2016): 348-364.
- Lane, Nick. "Cell biology: power games." Nature 443.7114 (2006): 901-904.
- Bathini, Mayukha, Chandavalli Ramappa Raghushaker, and Krishna Kishore Mahato. "The molecular mechanisms of action of photobiomodulation against neurodegenerative diseases: a systematic review." Cellular and Molecular Neurobiology 42.4 (2022): 955-971.
- Tatmatsu-Rocha, José Carlos, et al. "Mitochondrial dynamics (fission and fusion) and collagen production in a rat model of diabetic wound healing treated by photobiomodulation: comparison of 904 nm laser and 850 nm light-emitting diode (LED)." Journal of Photochemistry and Photobiology B: Biology 187 (2018): 41-47.
- Yu, Weihua, et al. "Stat2-Drp1 mediated mitochondrial mass increase is necessary for pro-inflammatory differentiation of macrophages." Redox biology 37 (2020): 101761.
- Bonda, David J., et al. "Mitochondrial dynamics in Alzheimer’s disease: opportunities for future treatment strategies." Drugs & aging 27 (2010): 181-192.
- Foo, Aaron Song Chuan, et al. "Mitochondrial dysfunction and Parkinson’s disease—Near-infrared photobiomodulation as a potential therapeutic strategy." Frontiers in Aging Neuroscience 12 (2020): 89.
- Wang, Ruimin, et al. "Photobiomodulation for global cerebral ischemia: targeting mitochondrial dynamics and functions." Molecular neurobiology 56 (2019): 1852-1869.
- Song, Ji Wei, et al. "Low-level laser facilitates alternatively activated macrophage/microglia polarization and promotes functional recovery after crush spinal cord injury in rats." Scientific reports 7.1 (2017): 620.
- Di Penta, Alessandra, et al. "Oxidative stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammation." PloS one 8.2 (2013): e54722.
- Engert, Andreas, et al. "Limits and value of chemotherapy in elderly patients." Medizinische Klinik (Munich, Germany: 1983) 89.11 (1994): 603-610.
- Sunemi, Simone Mitie, et al. "Post-resistance exercise photobiomodulation therapy has a more effective antioxidant effect than pre-application on muscle oxidative stress." Photochemical & Photobiological Sciences 20 (2021): 585-595.
- de Oliveira, Helenita Antonia, et al. "Photobiomodulation leads to reduced oxidative stress in rats submitted to high-intensity resistive exercise." Oxidative Medicine and Cellular Longevity 2018 (2018).
- Dos Santos, Solange Almeida, et al. "Effects of photobiomodulation therapy on oxidative stress in muscle injury animal models: a systematic review." Oxidative Medicine and Cellular Longevity 2017 (2017).
- Praticò, Domenico. "Oxidative stress hypothesis in Alzheimer’s disease: a reappraisal." Trends in pharmacological sciences 29.12 (2008): 609-615.
- Bradley, Melissa A., et al. "Elevated 4-hydroxyhexenal in Alzheimer's disease (AD) progression." Neurobiology of aging 33.6 (2012): 1034-1044.
- Mecocci, Patrizia, Usha MacGarvey, and M. Flint Beal. "Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease." Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society 36.5 (1994): 747-751.
- Jiang, Hui, et al. "CART mitigates oxidative stress and DNA damage in memory deficits of APP/PS1 mice via upregulating β amyloid metabolism associated enzymes." Molecular Medicine Reports 23.4 (2021): 1-12.
- Butterfield, D. Allan, et al. "Oxidatively induced structural alteration of glutamine synthetase assessed by analysis of spin label incorporation kinetics: relevance to Alzheimer's disease." Journal of neurochemistry 68.6 (1997): 2451-2457.
- Heo, Jin-Chul, et al. "Photobiomodulation (660 nm) therapy reduces oxidative stress and induces BDNF expression in the hippocampus." Scientific reports 9.1 (2019): 10114.
- Purushothuman, Sivaraman, et al. "Photobiomodulation with near infrared light mitigates Alzheimer’s disease-related pathology in cerebral cortex–evidence from two transgenic mouse models." Alzheimer's research & therapy 6 (2014): 1-13.
- Zhang, Jixiang, et al. "ROS and ROS-mediated cellular signaling." Oxidative medicine and cellular longevity 2016 (2016).
- Chen, Aaron CH, et al. "Low-level laser therapy activates NF-kB via generation of reactive oxygen species in mouse embryonic fibroblasts." PloS one 6.7 (2011): e22453.
- Barolet, Daniel, François Christiaens, and Michael R. Hamblin. "Infrared and skin: Friend or foe." Journal of Photochemistry and Photobiology B: Biology 155 (2016): 78-85.
- Huang, Ying‐Ying, et al. "Low‐level laser therapy (LLLT) reduces oxidative stress in primary cortical neurons in vitro." Journal of biophotonics 6.10 (2013): 829-838.
- Sommer, Andrei P. "Mitochondrial cytochrome c oxidase is not the primary acceptor for near infrared light—it is mitochondrial bound water: the principles of low-level light therapy." Annals of Translational Medicine 7.Suppl 1 (2019).
- Lima, Paula LV, et al. "Photobiomodulation enhancement of cell proliferation at 660 nm does not require cytochrome c oxidase." Journal of Photochemistry and Photobiology B: Biology 194 (2019): 71-75.
DOI: http://dx.doi.org/10.52155/ijpsat.v44.1.6160
Refbacks
- There are currently no refbacks.
Copyright (c) 2024 Maged Naser, Mohamed M. Nasr, Lamia H. Shehata
This work is licensed under a Creative Commons Attribution 4.0 International License.